TUCSON, Ariz., March 21, 2025 /PRNewswire/ — Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...

TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality ...

See accompanying notes to consolidated financial statements. View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate ...

TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and ...

Accelerate Diagnostics ( (AXDX)) has released its Q3 earnings. Here is a breakdown of the information Accelerate Diagnostics presented to its investors. Accelerate Diagnostics, Inc. is a company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Accelerate Diagnostics has filed ...

Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate ...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. In addition to the Accelerate Arc system ...